|
Chao Family Comprehensive Cancer Center Clinical Trials:
Head and Neck Cancer
|
|
Protocol#
|
Principal Investigator
|
Title
|
UCI 06-32 |
Ou |
A Pivotal Phase 2 Study of the Anti-Angiogenesis Agent AG-013736 in Patients with 131 I-refractory metastatic or Unresectable locally-advanced papillary, follicular, or Hurthle-cell thyroid cancer who are also refractory to, or intolerant of, or have clinical contraindication to, doxorubicin treatment (A4061027) |
| UCI 04-40 |
Ou |
A Phase II Study of Adjuvant Chemoradiation with Weekly Oxaliplatin in Patients with High Risk Resected Squamous Cell Carcinoma of the Head and Neck |
| UCI 03-58 |
Ramshinghani |
A Phase II Protocol of Intensity-Modulated Radiotherapy for Treatment of Previously Irradiated Recurrent Head and Neck Cancer |
| UCI 98-21 |
Armstrong |
Dysplastic Oral Epithelial Cell Line Development |
| UCI 05-46 |
Ou |
A Phase II Study of AlbuminBound-Paclitaxel (Abraxane) for Treatment of urrent or Metastatic Head and Neck Cancer |
For additional information on open UCI clinical trials please call toll-free 1-877-UC-STUDY or email ucstudy@uci.edu.
